GSK plc (LON:GSK)
1,485.00
-9.00 (-0.60%)
Sep 24, 2025, 6:31 PM BST
GSK plc Revenue
GSK plc had revenue of 7.99B GBP in the quarter ending June 30, 2025, with 1.29% growth. This brings the company's revenue in the last twelve months to 31.63B, up 0.59% year-over-year. In the year 2024, GSK plc had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.63B
Revenue Growth
+0.59%
P/S Ratio
1.89
Revenue / Employee
460.90K
Employees
68,629
Market Cap
59.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
ConvaTec Group | 1.72B |
Hikma Pharmaceuticals | 2.35B |
HUTCHMED (China) | 439.54M |
Genus | 672.80M |
Oxford Nanopore Technologies | 204.69M |
GSK plc News
- 15 hours ago - GSK plc (GSK) plc Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 hours ago - Pi Health to Collaborate with GSK to Enhance Clinical Research Services - Business Wire
- 1 day ago - GSK Seeks FDA Approval to Expand Leucovorin Use - GuruFocus
- 1 day ago - GSK to seek a label update for leucovorin as FDA says it can cure autism - Seeking Alpha
- 2 days ago - GSK to submit label update for Leucovorin at FDA's request, does not intend to market it for autism - CNBC
- 2 days ago - FDA approves drug that Trump due to suggest as autism treatment - Reuters
- 2 days ago - Here's Why GSK (GSK) is a Strong Growth Stock - Nasdaq
- 4 days ago - GSK spin-off Haleon eyes Tylenol takeover - This is Money